Menu
Not yet recruiting NCT07423871

ED PLWD/Care Partner Text Messaging

No phase Interventional Dementia Caregiver Emergency Department Mobile Health Technology (mHealth)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: CAPTURE Text Message Care Transition Support.
Who it may be relevant to
Registry conditions: Dementia, Caregiver, Emergency Department, Mobile Health Technology (mHealth). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Development and Pilot Testing of a Novel Text Messaging Intervention to Improve Emergency Department Care Transitions Among Care Partners of Persons Living With Cognitive Impairment

Overview

The purpose of this research study is to develop and test a text-messaging intervention for emergency department (ED) discharge care transitions experienced by caregivers of older adults with cognitive impairment.

Interventions

  • Behavioral CAPTURE Text Message Care Transition Support
    The CAPTURE intervention is a tailored, automated text messaging program designed to support care partners of persons living with cognitive impairment (PLWCI) during the 30-day period following an emergency department (ED) visit. It provides up to two messages per day, customized based on caregiver-identified needs, and addresses topics such as care transition guidance, symptom monitoring, caregiver well-being, community resources, and communication strategies. The content is evidence-informed a

Primary outcome measures

  • Enrollment rates [Time frame: 30 days after ED visit]
  • Message engagement [Time frame: 30 days after ED visit]
  • Retention rate [Time frame: 30 days after ED visit]
  • System Usability Scale (SUS) [Time frame: 30 days after ED visit]
  • Acceptability [Time frame: 30 days after ED visit]
Secondary outcome measures (3)
  • Preparedness for Caregiving Scale [Time frame: 30 days after ED visit]
  • Zarit Burden Interview score [Time frame: 30 days after ED visit]
  • Emergency Department revisits and hospitalizations [Time frame: 30 days after ED visit]

Eligibility criteria

Inclusion criteria

  • Care partners (family members or close contacts) of persons living with cognitive impairment (PLWCI) who were evaluated and discharged from the emergency department (ED)
  • Age 18 years or older
  • Able to read and understand English or Spanish
  • Owns a mobile phone capable of receiving SMS text messages
  • Provides informed consent to participate in the study
  • Care recipient (PLWCI) resides in a community setting (i.e., not in a long-term care facility)

Exclusion criteria

  • Care partner of a patient who is admitted to the hospital from the ED or transferred to a facility (e.g., skilled nursing facility)
  • Care partner who is already enrolled in another caregiving support trial or intervention study
  • Care partner who does not have regular access to a mobile phone with SMS capabilities
  • Care partner who is unable or unwilling to participate in follow-up over 30 days
  • Care partner of a patient enrolled in hospice or receiving end-of-life care

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Yale New Haven Hospital Emergency Departments — New Haven

Identifiers

NCT: NCT07423871 · 2000040692 · RFA-AG-24-015 · 1K76AG094954-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗